Further Illumination of the Test Threshold Approach in the Care of Emergency Department Patients With Symptoms of Pulmonary Embolism
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
Supervising editor: Steven M. Green, MD
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. Dr. Kline owns stock in BreathQuant Medical, LLC, which manufactures a breath device designed to diagnose and monitor for pulmonary embolism.
Publication date: Available online February 1, 2010.
Earn CME Credit: Continuing Medical Education is available for this article at: www.ACEP-EMedHome.com.
Reprints not available from the author.
PII: S0196-0644(10)00026-0
doi:10.1016/j.annemergmed.2010.01.005
© 2010 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
Refers to article:
-
Testing Low-Risk Patients for Suspected Pulmonary Embolism: A Decision Analysis
, 11 January 2010
